X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (31) 31
oncology (29) 29
female (27) 27
index medicus (23) 23
aged (21) 21
breast cancer (19) 19
breast neoplasms - drug therapy (16) 16
chemotherapy (16) 16
adult (15) 15
middle aged (15) 15
cancer (12) 12
treatment outcome (10) 10
aged, 80 and over (9) 9
male (9) 9
quality of life (8) 8
drug administration schedule (7) 7
elderly (7) 7
women (7) 7
cancer therapies (6) 6
care and treatment (6) 6
chemotherapy, adjuvant (6) 6
disease-free survival (6) 6
hematology, oncology and palliative medicine (6) 6
retrospective studies (6) 6
survival (6) 6
trastuzumab (6) 6
tumors (6) 6
adjuvant treatment (5) 5
antineoplastic agents - therapeutic use (5) 5
breast neoplasms - pathology (5) 5
combination (5) 5
fluorouracil - administration & dosage (5) 5
follow-up studies (5) 5
neoplasm staging (5) 5
patients (5) 5
prognosis (5) 5
research (5) 5
surgery (5) 5
survival analysis (5) 5
therapy (5) 5
trial (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
breast neoplasms - mortality (4) 4
breast-cancer (4) 4
cancer patients (4) 4
capecitabine (4) 4
disease progression (4) 4
endocrine therapy (4) 4
health aspects (4) 4
hematology (4) 4
italy (4) 4
mastectomy (4) 4
medical research (4) 4
medicine & public health (4) 4
paclitaxel (4) 4
paclitaxel - administration & dosage (4) 4
phase-ii trial (4) 4
quality-of-life (4) 4
administration, oral (3) 3
antibiotics, antineoplastic - administration & dosage (3) 3
antibodies, monoclonal, humanized - administration & dosage (3) 3
antineoplastic agents, hormonal - therapeutic use (3) 3
antineoplastic agents, phytogenic - adverse effects (3) 3
article (3) 3
breast (3) 3
breast neoplasms - genetics (3) 3
breast neoplasms - metabolism (3) 3
breast neoplasms - surgery (3) 3
deoxycytidine - administration & dosage (3) 3
deoxycytidine - analogs & derivatives (3) 3
endocrine nonresponsive (3) 3
erbb-2 protein (3) 3
immunology (3) 3
kaplan-meier estimate (3) 3
lapatinib (3) 3
medicine, general & internal (3) 3
metastasis (3) 3
neoplasm metastasis (3) 3
non-hodgkins-lymphoma (3) 3
obstetrics & gynecology (3) 3
paclitaxel - adverse effects (3) 3
pegylated liposomal doxorubicin (3) 3
phase-ii (3) 3
phase-iii trial (3) 3
postmenopausal women (3) 3
prospective studies (3) 3
radiotherapy (3) 3
receptor, erbb-2 - metabolism (3) 3
skin and connective tissue diseases (3) 3
surveys and questionnaires (3) 3
tamoxifen (3) 3
tamoxifen - therapeutic use (3) 3
toxicity (3) 3
1st-line treatment (2) 2
adjuvant chemotherapy (2) 2
adjuvant endocrine therapy (2) 2
advanced breast-cancer (2) 2
advanced kidney cancer (2) 2
age factors (2) 2
aged patients (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 7, pp. 848 - 858
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2018, Volume 379, Issue 2, pp. 122 - 137
Journal Article
British Journal of Cancer, ISSN 0007-0920, 04/2016, Volume 114, Issue 9, pp. 956 - 964
Journal Article
Journal Article
Radiotherapy and Oncology, ISSN 0167-8140, 01/2018, Volume 126, Issue 1, pp. 177 - 180
We conducted a prospective phase II multicentric trial to determine if radical radiation therapy to all metastatic sites might improve the progression-free... 
Oligometastases | Breast cancer | SBRT | TRASTUZUMAB | ONCOLOGY | COMBINATION | DOCETAXEL | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CHEMOTHERAPY | PACLITAXEL
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 01/2019, Volume 72, pp. 7 - 14
The post-neoadjuvant setting in early breast cancer represents an attractive scenario for adjuvant clinical trials, offering the opportunity to test new drugs... 
Post-neoadjuvant treatment | Breast cancer | Residual disease | pCR | MOLECULAR SUBTYPES | SYSTEMIC THERAPY | PATHOLOGICAL COMPLETE RESPONSE | TUMOR-INFILTRATING LYMPHOCYTES | STAGING SYSTEM | ONCOLOGY | ADJUVANT CAPECITABINE | GROWTH-FACTOR | PROGNOSTIC-SIGNIFICANCE | THYMIDINE PHOSPHORYLASE
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2015, Volume 10, Issue 9, p. e0136731
Journal Article
Radiation Oncology, ISSN 1748-717X, 05/2017, Volume 12, Issue 1, pp. 86 - 5
Journal Article
BMC Cancer, ISSN 1471-2407, 12/2014, Volume 14, Issue 1, pp. 954 - 954
Journal Article